November 27, 2024 2 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Jay S. Duker, MD, president and CEO of EyePoint Pharmaceuticals, shares an update on Duravyu for wet age-related macular degeneration. Duker discussed positive phase 2 data from the DAVIO 2 trial investigating Duravyu, an intravitreal insert that delivers vorolanib, a … [Read more...] about VIDEO: EyePoint shares updates on Duravyu for wet AMD, DME
News
AI-ready dataset released in type 2 diabetes study
A new study is releasing its flagship dataset, offering a wealth of data on the biomarkers and environmental influences that may play a role in the development of type 2 diabetes. By including participants ranging from healthy individuals to those at various stages of the disease, the research provides a unique, multifaceted perspective that goes beyond traditional diabetes … [Read more...] about AI-ready dataset released in type 2 diabetes study
Microglial activation in AMD: Hyperreflective retinal foci offer insights for disease progression and monitoring
Small hyperreflective retinal foci (HRF), identified on optical coherence tomography (OCT) images, reflect activated neuroretinal microglial cells involved in the pathogenesis of age-related macular degeneration (AMD). According to Elisabetta Pilotto, MD, FEBO, and colleagues, HRF with specific characteristics, known as aggregates of activated microglial cells, may indicate … [Read more...] about Microglial activation in AMD: Hyperreflective retinal foci offer insights for disease progression and monitoring
AI models offer hope for personalized AMD treatment plans
Age-related macular degeneration (AMD), a leading cause of blindness in developed countries, continues to present significant challenges as the number of cases rises globally. Neovascular AMD (nAMD) is commonly managed with intravitreal anti-vascular endothelial growth factor (VEGF) injections, guided by optical coherence tomography (OCT) imaging to evaluate macular anatomy. … [Read more...] about AI models offer hope for personalized AMD treatment plans
Macular Capillary Nonperfusion in Eyes With Proliferative Diabetic Retinopathy
This cohort study examines data for 63 patients over 12 months to assess how visual function and optical coherence tomography angiography changed in panretinal photocoagulation–treated stable eyes. … [Read more...] about Macular Capillary Nonperfusion in Eyes With Proliferative Diabetic Retinopathy
Visual System Changes After Chronic Mild TBI
This case-control study investigates if mild traumatic brain injury (TBI)–associated dysfunction can be diagnosed with a battery of assessments across the visual pathway. … [Read more...] about Visual System Changes After Chronic Mild TBI
Strongyloides stercoralis Choroiditis
This case report describes a patient whose autopsy revealed that the posterior choroid of the right eye had a focal eosinophil-rich inflammatory infiltrate with a cross-section of a possible degenerating Strongyloides stercoralis larva and a coiled, incompletely sectioned, filariform larva in a medium-caliber choroidal artery. … [Read more...] about Strongyloides stercoralis Choroiditis
Visual Deficits in Patients With Mild Traumatic Brain Injury
Vision problems, including light sensitivity and double vision, are among the most commonly reported symptoms following mild traumatic brain injury (mTBI). While most symptoms resolve within 6 months of mTBI, a substantial number of patients continue to report vision deficits months to years following their initial injuries. A better understanding of the neurobiological bases … [Read more...] about Visual Deficits in Patients With Mild Traumatic Brain Injury
Optic neuropathy as an initial manifestation of acute retinal necrosis caused by varicella zoster virus: a case report
We present the treatment and follow-up of a rare patient with acute retinal necrosis (ARN) with optic neuropathy as the first manifestation. … [Read more...] about Optic neuropathy as an initial manifestation of acute retinal necrosis caused by varicella zoster virus: a case report
Comparison of therapeutic effects of 0.05% Cyclosporine A versus 0.1% Fluorometholone in Chinese patients with mild dry eye unresponsive to artificial tears: a randomized control study
To assess and compare the therapeutic outcomes of 0.05% Cyclosporine A (CsA) ophthalmic solution versus 0.1% Fluorometholone (FML) eyedrops in Chinese patients with mild dry eye disease (DED) unresponsive to c... … [Read more...] about Comparison of therapeutic effects of 0.05% Cyclosporine A versus 0.1% Fluorometholone in Chinese patients with mild dry eye unresponsive to artificial tears: a randomized control study